“Aspen Capital has proven to be an outstanding partner for CLARA. Their operational and investment expertise has been instrumental in refining our go-to-market strategy. The Aspen team also connected us with key insurance prospects and channel partners, which played a major role in boosting our business development efforts and led to significant revenue opportunities. I am delighted to have Aspen as a partner.”

“I’ve been continually impressed by Aspen Capital’s willingness to roll up their sleeves and help Transcend  in a variety of ways. They genuinely dive deep to understand the nuances of our business, bringing a wealth of experience that is particularly invaluable for SaaS companies like ours. Their strategic insights and active engagement have been instrumental in guiding our growth and success.”

“The Aspen team has been an integral part of the Board and has been active and involved weekly with our Sales, Finance and Operating teams since our partnership began three years ago. They have brought their past experiences, market knowledge, and opinions to the table, and worked alongside our divisions to help them reach tip-top shape. We have had all the normal challenges any company has, but their collaborative approach to problem solving has been immensely helpful to us and allowed us to keep moving forward toward our goals.”

Acquired by SailPoint (NYSE: SAIL)

“Since making their first investment, Aspen has provided immeasurable support to ERP Maestro. Aspen was engaged in assessing nearly every aspect of the business. They quickly recognized where we needed support and without being overbearing they provided helpful assistance to the Company. They helped us put the scaffolding in place to scale and professionalize the organization and continued to push our thinking to help us get clarity around key strategic decisions. When working with a strategic partner, integrity is very important to us and they did everything they said they would do, and we are thrilled with our partnership. They played a key role in in creating value alongside management which lead to our ultimate sale to SailPoint.”

“Steve Jones of Aspen Capital was instrumental in the growth and development of NeoGenomics. Aspen closed its first investment in 2003 and continued to invest for years as the Company required growth capital. In addition, Steve was deeply involved in helping NeoGenomics refine its business model and strategy, and execute many strategic initiatives. Today, NeoGenomics is a recognized leader in Oncology Diagnostics with a multi-billion dollar market capitalization and Steve served as a trusted member of our Board for over 15 years.”